TOFACITINIB

NDC 70069-842 · Somerset Therapeutics, LLC

Generic nameTOFACITINIB

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)TOFACITINIB CITRATE

Strength10 mg/1

Pharmacologic classJanus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]

Marketing categoryANDA

Packages

70069-842-01 — 60 TABLET, FILM COATED in 1 BOTTLE (70069-842-01)

FDA lists these products with the same active ingredient.

59651-459 — TOFACITINIB, 59651-460 — TOFACITINIB, 59651-685 — TOFACITINIB, 60505-4858 — tofacitinib, 63539-012 — tofacitinib, 63539-016 — tofacitinib, 63539-029 — tofacitinib, 63539-501 — tofacitinib, 63539-502 — tofacitinib, 70069-841 — TOFACITINIB, 70095-008 — Tofacitinib, 70377-057 — Tofacitinib, 70710-1243 — tofacitinib, 70710-1353 — tofacitinib, 70710-1589 — tofacitinib, 70710-1727 — tofacitinib, 70771-1627 — tofacitinib, 70771-1628 — tofacitinib, 70771-1821 — tofacitinib, 70771-1967 — tofacitinib, +27 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.